Baronsmead Second Venture Trust (LON:BMD) Sets New 12-Month Low – Here’s What Happened

Shares of Baronsmead Second Venture Trust (LON:BMD) reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 50 ($0.63) and last traded at GBX 50 ($0.63), with a volume of 6083409 shares traded. The stock had previously closed at GBX 51 ($0.65).

Baronsmead Second Venture Trust Stock Down 2.0 %

The company has a market cap of £195.84 million, a PE ratio of 43.24 and a beta of 0.24. The stock’s 50 day simple moving average is GBX 52.70 and its two-hundred day simple moving average is GBX 54.40.

Baronsmead Second Venture Trust (LON:BMD) last announced its quarterly earnings results on Tuesday, December 24th. The company reported GBX 0.48 ($0.01) EPS for the quarter. Baronsmead Second Venture Trust had a net margin of 38.32% and a return on equity of 1.95%.

Baronsmead Second Venture Trust Increases Dividend

The company also recently disclosed a dividend, which will be paid on Monday, March 17th. Stockholders of record on Thursday, February 13th will be given a dividend of GBX 2.25 ($0.03) per share. The ex-dividend date is Thursday, February 13th. This is a boost from Baronsmead Second Venture Trust’s previous dividend of $1.75. This represents a dividend yield of 4.21%. Baronsmead Second Venture Trust’s payout ratio is currently 345.90%.

Insiders Place Their Bets

In related news, insider Adriana Stirling acquired 18,002 shares of the business’s stock in a transaction on Thursday, February 20th. The stock was purchased at an average cost of GBX 56 ($0.71) per share, for a total transaction of £10,081.12 ($12,785.19). Insiders own 0.15% of the company’s stock.

About Baronsmead Second Venture Trust

Baronsmead Second Venture Trust plc is a venture capital trust managed by ISIS Equity Partners LLP. It invests in a portfolio of unquoted companies in the United Kingdom. The trust primarily invests in the media, business services, consumer, information technology support services, technology-enabled companies, and healthcare sectors.